Navigation Links
ResearchMoz: Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020)
Date:12/12/2011

ALBANY, New York, December 12, 2011 /PRNewswire/ --

New Report Added in ResearchMoz Reports Database Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020) Published by IMARC.

With sales worth US$ 57 Million in 2010, biosimilars are still far from their billion dollar sales potential that most analysts believe they will generate. This market, however, unlike small molecule generics, is expected to be more akin to a marathon than a sprint. IMARC Group, one of the world's leading research and advisory firms, in its new report "Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020)" finds that biosimilars in the US will soon represent a multi-billion dollar market as they would be posing stiff competition to as many as twenty biological molecules during 2011-2020.

Browse the full Report:  http://www.researchmoz.com/biosimilar-follow-on-biologics-market-report-and-forecast-a-focus-on-the-us-2011-2020-report.html 


Findings from the report suggest that the historical performance of Omnitrope cannot be taken as a benchmark to gauge the potential of pipeline biosimilars as market acceptance for each biosimilar class is expected to vary significantly from one another. The report expects that the competition between branded biological drugs and their biosimilar counterparts would be more of a brand-brand competition than a brand-generic competition. The high costs involved in the development and launch of biosimilars are expected to l
'/>"/>

SOURCE ResearchMoz
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
2. Insmed Launches National Awareness Campaign Surrounding Follow-On Biologics
3. Insmed Provides Update on Follow-On Biologics and IPLEX(TM) Programs
4. CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R)
5. Insmed CEO to Present at Congressional Briefing on Follow-On Biologics
6. Interface Biologics Anti-Thrombic Additives Show Equivalent Efficacy to Commercial Heparinized Coatings
7. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
8. Bone Biologics Announces Significant Milestone for Spinal Fusion Surgery Using Recombinant Protein and Demineralized Bone Matrix
9. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
10. Food and Drug Administration Accepts Isolagens Biologics License Application for Full Review
11. CMC ICOS Biologics and Implicit Bioscience Ltd Announce IC14 Antibody Manufacturing Agreement and Patent License
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... IQ den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der jetzt ... interaktive PDF, verfügbar unter pharmaserialisation.com , zeigt ... sie jeweils in Kraft treten. Für ... nicht länger um das "ob", sondern darum, "wann" ...
(Date:9/19/2014)... VIENNA , Sept. 19, 2014 ... positive interim clinical data for its lead candidate ITCA ... diabetes patients with high baseline HbA1c levels at the ... for the Study of Diabetes (EASD). Data from the ... reduced levels of blood sugar in patients with poorly ...
(Date:9/19/2014)... Mass. , Sept. 19, 2014   Personal ... advanced cancer genome analysis and testing services, and ... and developing highly selective kinase inhibitors for genomically ... study of malignant mixed Mullerian tumors (MMMT), an ... system, also known as carcinosarcoma. The new ...
Breaking Medicine Technology:Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4
... 2011 Seal Shield LLC today announced ... for the iPad.  The product has been designed specifically ... use in hospital settings. The Seal Shield ... which is resistant to liquids including blood and bleach. ...
... MALVERN, Pa., Feb. 21, 2011 Today, Siemens (NYSE: ... Overhage, MD, PhD, as Chief Medical Informatics Officer (CMIO), of ... of the In diana Health Information Exchange ... this not-for-profit organization. In his role at Siemens, Marc will ...
Cached Medicine Technology:Siemens Appoints Overhage as New Chief Medical Informatics Officer 2
(Date:9/19/2014)... Food and Drug Administration approved a new type 2 diabetes ... of once-a-week injectable drugs that help manage blood sugar levels ... a new treatment option, which can be used alone or ... in the overall management of type 2 diabetes," Dr. Mary ... II, said in an agency news release. About ...
(Date:9/19/2014)... 2014 The Alliance for Bangladesh ... the National Fire Protection Association (NFPA), a recognized ... today in a Memorandum of Understanding signed by ... and other stakeholders with information, guidance and access ... health and safety of workers in ready-made garment ...
(Date:9/19/2014)... September 19, 2014 MetroMD, a leading anti-ageing ... “God Particle” of human health. This therapy has grown tremendously ... the therapy more effective, safe and dependable. It has far ... an opportunity to live a very healthy and active lifestyle ... of HGH therapy, a senior therapist at MetroMD said, “HGH ...
(Date:9/19/2014)... 2014 "I have difficulty putting in ... to stretching the skin around my eyes during the ... me to design a more convenient method of performing ... provides a quicker, easier, more sanitary method of putting ... this task manually, saves time and effort, and helps ...
(Date:9/19/2014)... (Sept. 19, 2014) - New research published today in ... Ebola cases could reach 6,800 in West Africa by ... are not enacted. , Arizona State University and ... the rate of rise in cases significantly increased in ... a mass quarantine was put in place, indicating that ...
Breaking Medicine News(10 mins):Health News:FDA Approves Another Weekly Injectable Drug for Type 2 Diabetes 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 3Health News:MetroMD Announces Better HGH Therapy - the ‘God Particle’ of Human Health 2Health News:Research predicts possible 6,800 new Ebola cases this month 2
... part of its campaign to be the,leading provider of ... will be hosting "A Matter of Heart" Health Fair ... hear the latest expert,medical advice on heart disease prevention ... staff will also be performing,free cholesterol, carotid bruit, blood ...
... baby,s cord blood with M.A.Z.E. Cord Blood Laboratories in Purchase, NY. They ... to have it just in case. , ... Cresskill, NJ ... to bank their baby,s cord blood with M.A.Z.E. Cord Blood ...
... Seattle, December 8, 2008 Epileptologists are constantly searching for ... brain down to its most fundamental cellular and molecular detail ... to locate and treat the specific cells, neurons or network ... Another is to restore cognitive function after possible injury from ...
... Dr. Timothy McDonald, physician, attorney,and chief safety and risk ... Medical Center, will give the keynote address titled "The Legal ... Association,for Respiratory Care (AARC) International Respiratory Congress at the Anaheim,Convention ... One of the issues ...
... malignancies , , TUESDAY, Dec. 9 (HealthDay News) -- An ... bone marrow cancers called myeloproliferative disorders (MPDs), according to ... cells. , The findings were to be presented Tuesday ... Hematology, in San Francisco. , The researchers, from Oregon ...
... more commonly known as ,lazy eye, could be drastically ... Nottingham. , Amblyopia is thought to affect up to 2.5 ... cent of all children,s eye appointments in the UK. Occlusion ... ,train, the affected eye is the main treatment for ...
Cached Medicine News:Health News:Estero Urgent Care to Hold 'A Matter Of Heart' Health Fair, a Free Event Focusing on Heart Disease Prevention to be Held on December 21st at Estero Community Park 2Health News:Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy 2Health News:Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy 3Health News:Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy 4Health News:Researchers report on convergence of technology 2Health News:'A Principled Approach to Medical Mistakes' To Be Addressed at 54th Annual International Congress for Respiratory Therapists 2Health News:'A Principled Approach to Medical Mistakes' To Be Addressed at 54th Annual International Congress for Respiratory Therapists 3Health News:Lazy eye treatment times could be drastically reduced, new research shows 2
Inquire...
... are accurate to 1 mm. In vivo results ... patients encapsulation scar tissue. Encapsulation scar tissue can ... therefore actual projection may vary from patient to ... surgeon with a scalpel or surgical scissors. All ...
... IQmarkTM Diagnostic Workstation Software offers a ... that digitally stores many different diagnostic ... Microsofts open-architecture products in mind, our ... integration (using ActiveX controls), networking, central ...
... engineered to set a new standard for ... enter the patient demographics, select auto report ... based system uses the latest in software ... of the IQmark Holter algorithm. Simple, intuitive ...
Medicine Products: